187 related articles for article (PubMed ID: 32678489)
1. The effectiveness of an indicated prevention programme for substance use in individuals with mild intellectual disabilities and borderline intellectual functioning: results of a quasi-experimental study.
Schijven EP; Hulsmans DHG; VanDerNagel JEL; Lammers J; Otten R; Poelen EAP
Addiction; 2021 Feb; 116(2):373-381. PubMed ID: 32678489
[TBL] [Abstract][Full Text] [Related]
2. Take it personal! Development and modelling study of an indicated prevention programme for substance use in adolescents and young adults with mild intellectual disabilities and borderline intellectual functioning.
Schijven EP; VanDerNagel JEL; Otten R; Lammers J; Poelen EAP
J Appl Res Intellect Disabil; 2021 Jan; 34(1):307-315. PubMed ID: 32990417
[TBL] [Abstract][Full Text] [Related]
3. Exploring the role of emotional and behavioral problems in a personality-targeted prevention program for substance use in adolescents and young adults with intellectual disability.
Hulsmans DHG; Otten R; Schijven EP; Poelen EAP
Res Dev Disabil; 2021 Feb; 109():103832. PubMed ID: 33360962
[TBL] [Abstract][Full Text] [Related]
4. Evaluating a selective prevention program for substance use and comorbid behavioral problems in adolescents with mild to borderline intellectual disabilities: Study protocol of a randomized controlled trial.
Schijven EP; Engels RC; Kleinjan M; Poelen EA
BMC Psychiatry; 2015 Jul; 15():167. PubMed ID: 26198744
[TBL] [Abstract][Full Text] [Related]
5. Personality dimensions and substance use in individuals with mild to borderline intellectual disabilities.
Poelen EA; Schijven EP; Otten R; Didden R
Res Dev Disabil; 2017 Apr; 63():142-150. PubMed ID: 27765413
[TBL] [Abstract][Full Text] [Related]
6. Substance use in individuals with mild to borderline intellectual disability: A comparison between self-report, collateral-report and biomarker analysis.
VanDerNagel JE; Kiewik M; van Dijk M; Didden R; Korzilius HP; van der Palen J; Buitelaar JK; Uges DR; Koster RA; de Jong CA
Res Dev Disabil; 2017 Apr; 63():151-159. PubMed ID: 27133469
[TBL] [Abstract][Full Text] [Related]
7. Substance use among individuals with mild intellectual disability or borderline intellectual functioning in residential care: Examining the relationship between drinking motives and substance use.
Schijven EP; Didden R; Otten R; Poelen EAP
J Appl Res Intellect Disabil; 2019 Jul; 32(4):871-878. PubMed ID: 30844128
[TBL] [Abstract][Full Text] [Related]
8. The mediating role of substance use motives in the relationship between personality dimensions and alcohol and drug use in adolescents and young adults with mild intellectual disabilities.
Poelen EAP; Schijven EP; Otten R
Addict Behav; 2022 Mar; 126():107173. PubMed ID: 34776302
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a selective intervention program targeting personality risk factors for alcohol misuse among young adolescents: results of a cluster randomized controlled trial.
Lammers J; Goossens F; Conrod P; Engels R; Wiers RW; Kleinjan M
Addiction; 2015 Jul; 110(7):1101-9. PubMed ID: 25892544
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of personality disorders in psychiatric outpatients with borderline intellectual functioning: Comparison with outpatients from regular mental health care and outpatients with mild intellectual disabilities.
Wieland J; Van Den Brink A; Zitman FG
Nord J Psychiatry; 2015; 69(8):599-604. PubMed ID: 25832758
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of a selective alcohol prevention program targeting personality risk factors: Results of interaction analyses.
Lammers J; Goossens F; Conrod P; Engels R; Wiers RW; Kleinjan M
Addict Behav; 2017 Aug; 71():82-88. PubMed ID: 28282524
[TBL] [Abstract][Full Text] [Related]
12. Evaluating a personalized treatment for substance use disorder in people with mild intellectual disability or borderline intellectual functioning: A study protocol of a multiple baseline across individuals design.
Gosens LCF; Otten R; Didden R; Poelen EAP
Contemp Clin Trials Commun; 2020 Sep; 19():100616. PubMed ID: 32743120
[TBL] [Abstract][Full Text] [Related]
13. Flexible assertive community treatment for individuals with a mild intellectual disability or borderline intellectual functioning: results of a longitudinal study in the Netherlands.
Neijmeijer LJ; Korzilius HPLM; Kroon H; Nijman HLI; Didden R
J Intellect Disabil Res; 2019 Aug; 63(8):1015-1022. PubMed ID: 30991450
[TBL] [Abstract][Full Text] [Related]
14. Substance use disorders in people with intellectual disability.
Didden R; VanDerNagel J; Delforterie M; van Duijvenbode N
Curr Opin Psychiatry; 2020 Mar; 33(2):124-129. PubMed ID: 31743126
[TBL] [Abstract][Full Text] [Related]
15. Brief Symptom Inventory symptom profiles of outpatients with borderline intellectual functioning and major depressive disorder or posttraumatic stress disorder: Comparison with patients from regular mental health care and patients with Mild Intellectual Disabilities.
Wieland J; Zitman FG
Res Dev Disabil; 2016; 51-52():153-9. PubMed ID: 26827151
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the Effectiveness of Take it Personal!+ in People With Mild Intellectual Disability or Borderline Intellectual Functioning and Substance Use Disorder: A Multiple Baseline Single-Case Experimental Study.
Gosens LCF; Poelen EAP; Didden R; de Jonge JM; Schellekens AFA; VanDerNagel JEL; Onghena P; Otten R
Behav Ther; 2024 Mar; 55(2):331-346. PubMed ID: 38418044
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of a selective, personality-targeted prevention program for adolescent alcohol use and misuse: a cluster randomized controlled trial.
Conrod PJ; O'Leary-Barrett M; Newton N; Topper L; Castellanos-Ryan N; Mackie C; Girard A
JAMA Psychiatry; 2013 Mar; 70(3):334-42. PubMed ID: 23344135
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment for substance-abusing people with intellectual disabilities: intervening on autonomous motivation for treatment entry.
Frielink N; Schuengel C; Kroon A; Embregts PJ
J Intellect Disabil Res; 2015 Dec; 59(12):1168-82. PubMed ID: 26369922
[TBL] [Abstract][Full Text] [Related]
19. Post-traumatic stress disorder and substance use disorder in individuals with mild intellectual disability or borderline intellectual functioning: A review of treatment studies.
Luteijn I; VanDerNagel JEL; van Duijvenbode N; de Haan HA; Poelen EAP; Didden R
Res Dev Disabil; 2020 Oct; 105():103753. PubMed ID: 32763655
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of a mindfulness-oriented substance use prevention program for boys with mild to borderline intellectual disabilities: study protocol for a randomised controlled trial.
Waedel L; Daubmann A; Zapf A; Reis O
BMC Public Health; 2020 Nov; 20(1):1780. PubMed ID: 33238932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
